IP Cases — 2025
5,670 decisions across all jurisdictions
Page 26 of 189 · 5,670 total
M/S.Sri Narasu'S Coffee Company Pvt. v.M/S.Shri Lakshmi Agro Agencies & The Registrar of Trademarks
The Madras High Court dismissed the rectification petition filed by M/S.Sri Narasu's Coffee Company Pvt. Ltd. against M/S.Shri Lakshmi Agro Agencies. The petitioner had sought to cancel the trademark registration 'Udhaiyam' in Class 30, citing grounds for invalidity. However, both parties subsequently entered into a Memorandum of Compromise and filed an additional joint memo requesting withdrawal. Consequently, the court accepted the request and dismissed the petition as withdrawn.
M/s.Sri Narasu'S Coffee Company Pvt.Ltd. v.S.Sudhakar and S.Dinakar (Partners of M/s.Shri Lakshmi Agro Foods)
M/s.Sri Narasu'S Coffee Company Pvt.Ltd. had filed a petition seeking the rectification and cancellation of the trademark 'Udhaiyam,' registered by S.Sudhakar and S.Dinakar under Application No.1359359 in Class 29. However, both parties subsequently entered into a Memorandum of Compromise dated October 10, 2025. Consequently, the Madras High Court dismissed the petition as withdrawn, resolving the dispute amicably.
Occlutech GmbH v.Lepu Medical (Europe) Cooperatief U.A. and Lepu Medical Technology (Beijing) Co., Ltd.
Occlutech GmbH, proprietor of European Patent EP 2 387 951 B1 covering a braided implantable occlusion device, sought provisional measures against Lepu Medical entities for alleged infringement with their 'MemoCarna ASD' and 'MemoCarna VSD' devices. The Local Division Hamburg held that the Defendants' recent CE-mark approval, combined with their public marketing activities and trade fair participation, established imminent infringement and territorial jurisdiction in Germany. The court granted the preliminary injunction, ordering the Defendants to cease and desist from offering, placing on the market, or using the infringing devices in Germany, France, Italy, the Netherlands, and Ireland, with a penalty of up to EUR 250,000 per non-compliance.
Amycel LLC v.XXX
Amycel LLC, proprietor of European Patent EP 1 993 350 B2 relating to brown mushrooms for commercial production, brought an infringement action against a Polish defendant for selling a competing brown mushroom strain called 'Cayene'. The defendant failed to file a timely Statement of Defence, leading to a decision by default after a Rule 275 order. The Court confirmed the orders previously granted in provisional measures proceedings, finding that the mushroom strain was not excluded from patentability under Article 53(b) EPC and that infringement was established.
Toyota Motor Corporation et al. v.Emerging Automotive LLC
Toyota’s IPR petition challenging Emerging Automotive’s vehicle‑profile patent was instituted after the Board found a reasonable likelihood of unpatentability for claims 10‑20.
Toyota Motor Corporation et al. v.Emerging Automotive LLC
Toyota Motor Corp. sought to invalidate Emerging Automotive’s vehicle‑profile patent. The PTAB found a reasonable likelihood of success and instituted the IPR, focusing on obviousness over several prior‑art references.
GE Healthcare Ltd. et al. v.The Johns Hopkins University et al.
GE Healthcare petitions to invalidate Johns Hopkins’s 11,938,201 patent covering FAP‑targeting radiopharmaceuticals, arguing that claims 1‑3 are obvious over US‑633, US‑121, Meletta and Jansen references.
Terumo BCT, Inc v.Haemonetics Corporation
Terumo BCT has filed a Post‑Grant Review petition challenging all 30 claims of Haemonetics’ plasma‑collection patent. The challenger asserts anticipation, obviousness, lack of patent‑eligible subject matter, and multiple §112 deficiencies. The petition is pending PTAB institution.
Kia America, Inc. et al. v.Emerging Automotive LLC
Kia and Toyota have filed a PTAB post‑grant review petition challenging Emerging Automotive’s vehicle‑key sharing patent (US 12,337,715). Petitioners allege obviousness over four prior‑art references and assert lack of written description for key claim limitations. They seek institution and cancellation of claims 1‑24.
Toyota Motor Corporation et al. v.Emerging Automotive LLC
Toyota seeks to invalidate Emerging Automotive’s U.S. Patent 12,337,716 covering cloud‑based vehicle settings by alleging obviousness over multiple prior art references. The petition requests the Board to institute an IPR and cancel all 13 claims.
Toyota Motor Corporation et al. v.Emerging Automotive LLC
Toyota and Kia have filed an IPR petition seeking cancellation of all 18 claims of Emerging Automotive’s vehicle e‑key patent, alleging obviousness over multiple prior‑art references. The petition details four statutory grounds under 35 U.S.C. §103.
Samsung Electronics Co., Ltd. et al. v.Massively Broadband LLC
Samsung has filed an IPR petition seeking cancellation of all 31 claims of Massively Broadband’s ’358 patent covering multiband antenna arrays. The petition relies on multiple prior‑art references to argue obviousness under 35 U.S.C. §103.
Stanley Black & Decker, Inc. et al. v.Howmet Aerospace Inc.
Stanley Black & Decker has filed an IPR petition challenging Howmet Aerospace’s ’358 blind fastener patent, asserting that all 20 claims are obvious over prior art such as Corbett, Kleinman, and Brewer. The petition outlines four §103 grounds and seeks institution of the trial.
Kia America, Inc. et al. v.Emerging Automotive LLC
The PTAB denied institution of the Post-Grant Review (PGR) for Kia America against Emerging Automotive, finding the petitioner failed to meet the reasonable likelihood of prevailing standard.
Toyota Motor Corporation et al. v.Emerging Automotive LLC
The PTAB denied institution in certain IPR proceedings involving Toyota Motor Corporation and Emerging Automotive LLC, finding the petitioner failed to meet the reasonable likelihood of prevailing standard.
GE Healthcare Ltd. et al. v.The Johns Hopkins University et al.
The PTAB granted institution for IPR2026-00069, allowing GE Healthcare Ltd. to challenge claims in patent 11938201 held by The Johns Hopkins University.
Toyota Motor Corporation et al. v.Emerging Automotive LLC
The PTAB granted institution for IPR2026-00059 involving Toyota Motor Corporation and Emerging Automotive LLC. The Board found the petitioner demonstrated a reasonable likelihood of prevailing on at least one challenged claim.
Shangrao Xinyuan Yuedong Technology Development Co., Ltd v.LONGi Solar Technologie GmbH & Ors.
The Claimant filed a patent infringement action against five Defendants concerning European patent EP 3 297 043 B1. Following settlement negotiations, the Claimant and Defendants 1–4 reached a comprehensive settlement agreement, and Defendant 5 agreed to the withdrawal. The Court permitted the withdrawal, declared the proceedings closed, ordered each party to bear its own extrajudicial costs, and granted the Claimant a 60% reimbursement of court fees (€6,600).
Meril Life Sciences Private Ltd., Meril GmbH, Meril Italy S.r.l. v.Edwards Lifesciences Corporation
The Meril entities sought revocation of Edwards Lifesciences' European patent EP 4 151 181 B1, which relates to a radially collapsible and expandable prosthetic heart valve with an outer skirt having axial slack. Edwards counterclaimed for infringement based on Meril's 'Octacor System' and 'Octapro System' products. The court rejected the revocation action, maintained the patent as amended by Auxiliary Request 2, and found infringement, granting an injunction (with an exception for XL-size valves exceeding 30 mm in diameter) along with information, delivery, and penalty payment orders.
Foleon Inc. et al. v.TURTL SURF & IMMERSE LIMITED
Foleon seeks a Director review to compel entry of adverse judgment after Turtl Surf disclaimed all challenged claims of its interactive‑document patent. The petitioner argues the Board erred in denying a motion for adverse judgment, citing precedent where such judgments were entered pre‑institution.
Foleon Inc. et al. v.TURTL SURF & IMMERSE LIMITED
Foleon’s request for Director review to impose an adverse judgment on Turtl Surf & Immerse was denied. The Patent Owner argued procedural impropriety and reliance on established PTAB precedent rejecting adverse judgments after a disclaimer.
Foleon Inc. et al. v.TURTL SURF & IMMERSE LIMITED
The USPTO Director denied Foleon Inc.’s request for review of the decision to deny institution of an IPR against Turtl Surf & Immerse Limited’s patent 12,118,290. The denial leaves the institution decision unchanged.
Foleon Inc. et al. v.TURTL SURF & IMMERSE LIMITED
Foleon has filed an IPR petition seeking cancellation of 18 claims of Turtl’s ’290 patent covering modular document generation, arguing the claims are obvious over multiple prior‑art references and that discretionary denial is unwarranted.
Samsung Electronics Co., Ltd. et al. v.Kannuu Pty. Ltd.
The PTAB granted institution for IPR2026-00071, allowing Samsung Electronics to challenge Kannuu's patent 11573939.
ONWARD Medical N.V. v.Niche Biomedical, Inc.
ONWARD Medical N.V. sought provisional measures against Niche Biomedical, Inc. before the Local Chamber Munich of the Unified Patent Court, alleging infringement of European Patent EP 3 421 081 B1 (relating to a neuromodulation system) by Niche Biomedical's 'ExaStim' stimulation system in Germany and France. The court rejected the application for interim measures, along with the auxiliary requests based on alternative claim formulations, holding that such auxiliary requests signal doubts about the validity of the patent as granted and are generally inadmissible in Art. 62 EPGÜ proceedings. The respondent's application for preliminary cost reimbursement of €168,000 was also rejected for lack of substantiation.
Edwards Lifesciences Corporation v.Meril GmbH, Meril Life Sciences Pvt Ltd., and Meril Italy S.r.l.
This case concerns an application for a cost decision by Edwards Lifesciences Corporation following a 4 April 2025 order requiring the three Meril defendants to jointly and severally bear the costs of the proceedings. Edwards sought reimbursement of EUR 774,696.49 in costs of representation, court fees, travel expenses, and other costs, while Meril contested the necessity and proportionality of various travel-related expenses. The Local Division Munich, through Judge-Rapporteur Dr. Matthias Zigann, held that UPC representatives have broad discretion in determining how to effectively represent their parties, and that the disputed travel costs were marginal relative to the overall costs, warranting award at the judge's discretion.
Hewlett-Packard Development Company, L.P. v.Andreas Rentmeister e.K. and Shenzhen Moan Technology Co., Ltd.
Hewlett-Packard Development Company, L.P. filed an application for provisional measures against Andreas Rentmeister e.K. and Shenzhen Moan Technology Co., Ltd. for alleged infringement of EP 3 835 965 B1, which relates to logic circuitry for replaceable print apparatus components. Defendant 1 reached a settlement with HP and agreed not to defend against the main motions, while service to Defendant 2 in China had not been completed. The Düsseldorf Local Division issued an order by default against Defendant 1, granting the preliminary injunction, information orders, and penalty payments, while reserving decision on costs and the application against Defendant 2.
AX Wireless, LLC v.Xiaomi Inc., Xiaomi Corporation, Xiaomi Technology Germany GmbH, and Xiaomi Technology Netherlands B.V.
AX Wireless, LLC filed a patent infringement action against four Xiaomi entities before the Local Division Munich of the Unified Patent Court concerning European Patent No. EP3072324. The Defendants requested an extension and alignment of procedural deadlines for all four Defendants so that a consolidated defence could be filed, and the Claimant consented. The Court granted the request, aligning the deadlines for all Defendants.
Abbott Diabetes Care Inc. v.Sinocare Inc. and A.Menarini Diagnostics s.r.l.
Abbott Diabetes Care sought provisional measures before the Unified Patent Court against Sinocare and Menarini concerning European patent EP 4 344 633 for 'Analyte Sensor Assemblies' related to continuous glucose monitoring (CGM) systems. Abbott alleged that the GlucoMen iCan CGM system, manufactured by Sinocare and distributed by Menarini in Europe, infringed its patent. The court granted the preliminary injunction, finding Abbott had established a strong prima facie case of infringement, the patent appeared valid, urgency existed, and the balance of interests favored Abbott.
Terumo BCT, Inc. v.Haemonetics Corporation
Terumo BCT has filed an IPR petition challenging all 30 claims of Haemonetics’ plasma‑collection patent, arguing they are obvious over the Lavender and Fletcher‑Haynes systems (and Min for a subset). The petition relies on detailed algorithmic comparisons and cites §103 unpatentability.
Facing a similar IP matter?
Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.